account_id none on file
legal_name GT Biopharma, Inc.
ticker GTBP
cik 109657
domain gtbiopharma.com
linkedin_company_url https://www.linkedin.com/company/gtbiopharmainc/about/
entry_point_account_id none on file
name GT Biopharma Inc.
exchange Nasdaq
sector Health Care
hq San Francisco, CA, United States
sector index/company/sector/health-care/
calls 0 filings 1 executives 5 family 0
why_nownone on file
callsnone on file
filings
TWF was seeking per diem liquidated damages based on the terms of alleged Notes. On July 14, 2023, the Company filed a motion to dismiss for improper forum because the terms of the Notes, as alleged, require disputes to be filed in New York state and federal courts.
filing / Aug 14, 2026 / receipt
executives
| Alan L. Urban | Chief Financial Officer | - | receipt |
| Charles J. Casamento | Chairman | - | receipt |
| David Saloff | Chief Executive Officer | - | receipt |
| Michael Breen | Executive Chairman, Board of Directors, Chief Executive Officer | - | receipt |
| Michael D. Centron | Vice President and Chief Financial Officer | - | receipt |
familynone on file
upcoming
| 2026-11-13 | earnings call | scheduled | ir |
changes
| 2025-05-05 | Chief Executive Officer, appointed | sec_8k |
| 2024-06-07 | Chief Financial Officer, appointed | sec_8k |
| 2023-05-04 | Chairman, appointed | sec_8k |
| 2019-03-21 | director, departed | sec_8k |
| 2018-07-05 | Chief Executive Officer, appointed | sec_8k |
| 2014-11-20 | Chief Executive Officer, departed | sec_8k |
| 2011-11-01 | Chairman of the Board, departed | sec_8k |
| 2011-11-01 | Chief Financial Officer, departed | sec_8k |
| 2011-08-31 | Chief Executive Officer, appointed | sec_8k |
| 2009-04-01 | Chairman, departed | sec_8k |
| 2008-09-10 | director, departed | sec_8k |
| 2008-06-24 | Chief Operating Officer, departed | sec_8k |
mcp_package_hint
slug gt-biopharma-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$